Foghorn Therapeutics Inc.

Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: FHTX

Foghorn Therapeutics Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its shares trade on Nasdaq under the ticker FHTX.

Profile compiled from public records. Is this your company? Request a correction or update

Foghorn Therapeutics at a glance

Typepharmaceutical company

HeadquartersCambridge, Massachusetts, United States

Stock listingNasdaq: FHTX

SEC industryPharmaceutical Preparations

SEC CIK1822462

Frequently asked questions about Foghorn Therapeutics

Where is Foghorn Therapeutics headquartered?

Foghorn Therapeutics Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Foghorn Therapeutics do?

Foghorn Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Foghorn Therapeutics a public company?

Yes. Foghorn Therapeutics Inc. trades on Nasdaq under the ticker FHTX.

Similar companies

Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
Visterra, Inc.Cambridge, Massachusetts, United States
Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
QurAlis CorpCambridge, Massachusetts, United States
Apnimed, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences